TY  - JOUR
TI  - Successful treatment with convalescent plasma in
Covid-19 disease in relaps/refractory multiple myeloma
AB  - The Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus detected in the Wuhan Province of the People's Republic of
China caused a pandemic in a very short time all over the world.
Convalescent plasma (CP) therapy is a passive antibody therapy that has been shown to be effective in epidemic periods. CP therapy
has been of interest in the treatment of infection with no vaccine or specific treatment, such as the Sars-CoV-2 infection that causes
COVID-19.
We aimed to report our CP experience in Sars-Cov-2 infection in our relapsed / refractory Multiple myeloma (MM) patient.
AU  - SARICI, AHMET
AU  - ERKURT, MEHMET ALI
AU  - KUKU, IRFAN
AU  - Özgül, Mustafa
AU  - Kaya, Emin
AU  - BERBER, Ilhami
AU  - Biçim, Soykan
DO  - 10.5455/annalsmedres.2021.02.191
PY  - 2021
JO  - Annals of Medical Research
VL  - 28
IS  - 12
SN  - 2636-7688
SP  - 2239
EP  - 2241
DB  - TRDizin
UR  - http://search/yayin/detay/514741
ER  -